Brief: Senti Bio Announces First Quarter 2023 Results And Pipeline Updates
Senti Biosciences Inc SNTI.O :
* SENTI BIO ANNOUNCES FIRST QUARTER 2023 RESULTS AND
PIPELINE
UPDATES
* SENTI BIOSCIENCES INC - CONTINUE TO EXPECT CASH RUNWAY
THROUGH
AT LEAST 1Q 2024
* SENTI BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.42
Source text for Eikon: ID:nGNX52MXc2
Further company coverage: SNTI.O
Recent news on Senti Biosciences Holdings
See all newsBrief: Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder
Senti Biosciences Q1 net loss narrows on cost reduction
Brief: Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy
Brief: Senti Biosciences Announces Holding Company Reorganization Effective By April 16, 2026 - SEC Filing
Senti Biosciences Q4 revenue misses analyst estimates